Testosterone is not just a “male hormone.” Women need it too. And pretending otherwise has left countless women struggling through midlife while being told everything looks “normal.”
While the Pap identifies the cell changes, the HPV test determines the root cause before those changes even happen. Both tests have saved lives. But they are not interchangeable, and treating them as such puts the patient at risk.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Women’s health platform Xella Health launched with a $499-per-year membership. The platform provides women the kind of connected healthcare that has typically only been available through expensive concierge medicine, said CEO Kelly Lacob.
The issue is not only functional. It is experiential. Many women do not need more scores. They need continuity, context, and support that feels companionable rather than corrective.
Winona launched a new research initiative to fund and support menopause and women's health research.
Capital is flowing into the broader women’s health ecosystem at a pace we have not seen before. The practices that will capture value from that momentum are the ones that get their operational house in order now.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Innovation in women’s health technology is about improving input data, refining performance criteria and ensuring design assumptions align with biological reality and real-world usage. When those fundamentals are in place, products are more accurate, more trustworthy and more likely to be adopted by clinicians and consumers alike.
A PwC report finds that women’s health is evolving into a much larger, high-growth market as investment expands beyond reproductive care, though it remains underfunded and under-researched.
Our biggest healthcare problems aren’t only cost or access, but the breakdown in how diagnoses are made, especially for women. Digital health’s new era of AI and real-time data is the most promising solution I’ve seen to fix this, but for these tools to work for women, they must be built on data that actually includes them.
Virtual women’s health provider Midi Health has reached unicorn status after raising a $100 million Series D, with investors backing its insurance-covered, direct-to-consumer model. The company is positioning itself as a long-term, virtual “hospital without walls” designed to meet women’s health needs across midlife and beyond.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
In this episode, we’re joined by Anna Jeter, co-founder and chief regulatory officer of AOA Dx. We dive into AOA Dx’s recent report on women's health exits.
We are only beginning to see how AI can impact women's health. As these technologies advance and become more integrated into healthcare workflows, we can expect more personalized care pathways that address women's needs across different life stages.
Maven Clinic launched a research institute to build and share evidence on the impact of digital care for women and families.
Wellcome Leap and Medicines360 have partnered to develop affordable tools to detect pregnancy complications earlier and reduce stillbirths worldwide.
Pomelo's Series C round was led by Stripes and included participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup and SV Angel.